BioNTech grants equity awards to Chief People Officer
BioNTech SE reported that Chief People Officer Kylie Jimenez received new equity-based compensation.
Rhea-AI Filing Summary
BioNTech SE reported that Chief People Officer Kylie Jimenez received new equity-based compensation. She was granted 8,391 performance share units, each economically equivalent to one ordinary share, and options over 10,488 ordinary shares.
The performance share units and options both vest annually in equal installments over four years starting on the first anniversary of the grant date and become exercisable four years after the grant date, subject to performance-based and other conditions. The option has an exercise price of EUR 89.38 and may be settled in ordinary shares, ADSs, and/or cash at the supervisory board’s election.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 18,879 shares
Grant/Award
2 txns
Insider
Jimenez Kylie
Role
Chief People Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Option (right to buy) | 10,488 | $0.00 | $0.00 |
| Grant/Award | Performance Share Unit | 8,391 | $0.00 | $0.00 |
Holdings After Transaction:
Option (right to buy) — 10,488 contracts (Direct);
Performance Share Unit — 8,391 contracts (Direct)
Footnotes (4)
- F1. The exercise price of this option is EUR 89.38. Subject to adjustment such that the trading price of an American Depositary Share ("ADS") as of an exercise date does not exceed 800% of the grant date exercise price.
- F2. The option vests annually in equal installments over four years commencing on the first anniversary of the grant date and becomes exercisable four years after the grant date, subject to certain performance-based and other conditions.
- F3. The option may be settled in ordinary shares, ADSs and/or cash at the election of the supervisory board.
- F4. Each performance share unit ("PSU") is the economic equivalent of one ordinary share of the Issuer and represents a right to receive, at the Issuer's option, one ordinary share, one ADS representing one ordinary share, or a cash payment or another form of settlement equal to the economic value thereof. PSUs vest annually in equal installments over four years commencing on the first anniversary of the grant date and become exercisable four years after the grant date, subject to the achievement of certain performance targets based on the market price of the Issuer's ordinary shares relative to the Nasdaq Biotechnology Index (or a comparable successor index) and the Reporting Person's continued service through each such date.
Key Figures
Performance share units granted: 8,391 units
Options granted: 10,488 options
Option exercise price: EUR 89.38 per share
+3 more
6 metrics
Performance share units granted
8,391 units
Grant to Chief People Officer Kylie Jimenez
Options granted
10,488 options
Right to buy ordinary shares
Option exercise price
EUR 89.38 per share
Exercise price for granted options
PSU-to-share ratio
1 PSU : 1 share
Each PSU equals one ordinary share economically
Vesting period
4 years
Annual installments starting on first anniversary of grant
Option exercisability
After 4 years
Becomes exercisable four years after grant date
Key Terms
Performance Share Unit, American Depositary Share, Nasdaq Biotechnology Index, exercise price, +1 more
5 terms
Nasdaq Biotechnology Index financial
"based on the market price of the Issuer's ordinary shares relative to the Nasdaq Biotechnology Index"
A stock index that tracks the performance of biotechnology companies listed on the NASDAQ stock exchange, combining many firms into a single measure of the sector’s movement. Think of it as a thermometer or basket that shows whether biotech stocks are generally rising or falling; investors use it to gauge sector health, compare individual holdings against the industry, and as the basis for funds that let you invest in the whole group at once.
exercise price financial
"The exercise price of this option is EUR 89.38."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
performance-based conditions financial
"subject to certain performance-based and other conditions."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did BioNTech (BNTX) grant to Kylie Jimenez?
BioNTech granted Kylie Jimenez 8,391 performance share units and options over 10,488 ordinary shares. Both awards are part of her compensation package and are tied to multi-year vesting and performance conditions.
What are the key terms of the stock options granted by BioNTech (BNTX)?
The options cover 10,488 ordinary shares with an exercise price of EUR 89.38. They vest in equal annual installments over four years and become exercisable four years after grant, subject to performance and other conditions.
When do Kylie Jimenez’s new BioNTech (BNTX) equity awards vest and become exercisable?
Both the performance share units and options vest annually in equal installments over four years, starting on the first anniversary of grant. They become exercisable four years after the grant date, subject to meeting specified conditions.
Are BioNTech (BNTX) performance targets tied to any index for these PSUs?
Yes. The performance share units depend on share price performance relative to the Nasdaq Biotechnology Index or a comparable successor index, along with the reporting person’s continued service through the vesting dates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
